Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BAJAJHCARENSE
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 12% | -1% | -2% | 13% |
| 7% | -28% | -28% | -50% |
| - | - | -9% | -31% |
| 16% | 11% | 4% | 4% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BAJAJHCARE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 350.15 | ₹1188 Cr | 51.59 | 4.13 | 15.43 | ₹16 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹17 Cr | ₹16 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹1 Cr | ₹18 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹515 Cr | ₹433 Cr | ₹265 Cr | ₹354 Cr | ₹315 Cr | ₹245 Cr | ₹164 Cr | ₹122 Cr | ₹107 Cr | ₹92 Cr | ₹82 Cr | ₹78 Cr | ₹28 Cr | ₹25 Cr | ₹27 Cr | ₹26 Cr | ₹22 Cr | ₹9 Cr |
| ₹515 Cr | ₹433 Cr | ₹265 Cr | ₹354 Cr | ₹315 Cr | ₹245 Cr | ₹164 Cr | ₹82 Cr | ₹66 Cr | ₹92 Cr | ₹40 Cr | ₹35 Cr | ₹28 Cr | ₹25 Cr | ₹27 Cr | ₹26 Cr | ₹22 Cr | ₹9 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹40 Cr | ₹41 Cr | ₹0 | ₹42 Cr | ₹43 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹533 Cr | ₹466 Cr | ₹278 Cr | ₹368 Cr | ₹328 Cr | ₹258 Cr | ₹178 Cr | ₹129 Cr | ₹114 Cr | ₹99 Cr | ₹89 Cr | ₹82 Cr | ₹31 Cr | ₹29 Cr | ₹30 Cr | ₹30 Cr | ₹26 Cr | ₹13 Cr |
| ₹48 Cr | ₹65 Cr | ₹39 Cr | ₹94 Cr | ₹66 Cr | ₹80 Cr | ₹23 Cr | ₹16 Cr | ₹20 Cr | ₹24 Cr | ₹27 Cr | ₹18 Cr | ₹9 Cr | ₹16 Cr | ₹16 Cr | ₹11 Cr | ₹26 Cr | ₹28 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹60 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹6 Cr | ₹11 Cr |
| -₹11 Cr | -₹19 Cr | -₹22 Cr | ₹50 L | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹84 L | ₹82 L | ₹2 L | -₹28 L | -₹70 L | -₹22 L | -₹27 L | -₹35 L | -₹23 L |
| ₹13 Cr | ₹25 L | ₹57 L | ₹76 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹7 Cr | ₹5 Cr | ₹6 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹77 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹57 Cr | ₹51 Cr | ₹23 Cr | ₹96 Cr | ₹71 Cr | ₹85 Cr | ₹27 Cr | ₹20 Cr | ₹23 Cr | ₹28 Cr | ₹32 Cr | ₹22 Cr | ₹14 Cr | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹31 Cr | ₹39 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹115 Cr | ₹100 Cr | ₹89 Cr | ₹85 Cr | ₹105 Cr | ₹69 Cr | ₹57 Cr | ₹30 Cr | ₹43 Cr | ₹19 Cr | ₹16 Cr | ₹23 Cr | ₹31 Cr | ₹20 Cr | ₹19 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr |
| ₹30 Cr | ₹37 Cr | ₹51 Cr | ₹48 Cr | ₹31 Cr | ₹25 Cr | ₹21 Cr | ₹26 Cr | ₹26 Cr | ₹20 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹2 Cr | ₹76 L |
| ₹164 Cr | ₹134 Cr | ₹261 Cr | ₹289 Cr | ₹176 Cr | ₹88 Cr | ₹58 Cr | ₹55 Cr | ₹55 Cr | ₹39 Cr | ₹42 Cr | ₹37 Cr | ₹49 Cr | ₹47 Cr | ₹35 Cr | ₹30 Cr | ₹0 | ₹0 |
| ₹1 Cr | ₹1 Cr | ₹12 L | ₹14 Cr | ₹10 Cr | ₹18 L | ₹52 L | ₹7 Cr | ₹7 Cr | ₹15 Cr | ₹10 Cr | ₹5 Cr | ₹1 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr |
| ₹310 Cr | ₹272 Cr | ₹402 Cr | ₹435 Cr | ₹322 Cr | ₹183 Cr | ₹138 Cr | ₹117 Cr | ₹131 Cr | ₹93 Cr | ₹88 Cr | ₹85 Cr | ₹99 Cr | ₹85 Cr | ₹74 Cr | ₹65 Cr | ₹28 Cr | ₹21 Cr |
| ₹913 Cr | ₹814 Cr | ₹743 Cr | ₹899 Cr | ₹721 Cr | ₹526 Cr | ₹343 Cr | ₹267 Cr | ₹268 Cr | ₹219 Cr | ₹209 Cr | ₹189 Cr | ₹145 Cr | ₹130 Cr | ₹121 Cr | ₹107 Cr | ₹85 Cr | ₹74 Cr |
| ₹24 Cr | ₹35 Cr | ₹21 Cr | ₹21 Cr | ₹14 Cr | ₹15 Cr | ₹25 Cr | ₹19 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹8 Cr | ₹11 Cr | ₹6 Cr | ₹35 L | ₹17 L |
| ₹233 Cr | ₹223 Cr | ₹332 Cr | ₹414 Cr | ₹257 Cr | ₹181 Cr | ₹91 Cr | ₹81 Cr | ₹87 Cr | ₹75 Cr | ₹81 Cr | ₹69 Cr | ₹70 Cr | ₹70 Cr | ₹61 Cr | ₹47 Cr | ₹31 Cr | ₹39 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹473 Cr | ₹436 Cr | ₹423 Cr | ₹525 Cr | ₹402 Cr | ₹329 Cr | ₹268 Cr | ₹222 Cr | ₹210 Cr | ₹200 Cr | ₹191 Cr | ₹162 Cr | ₹100 Cr | ₹90 Cr | ₹74 Cr | ₹57 Cr | ₹49 Cr | ₹43 Cr |
| ₹224 Cr | ₹198 Cr | ₹170 Cr | ₹159 Cr | ₹132 Cr | ₹121 Cr | ₹106 Cr | ₹94 Cr | ₹83 Cr | ₹72 Cr | ₹62 Cr | ₹53 Cr | ₹45 Cr | ₹36 Cr | ₹28 Cr | ₹22 Cr | ₹18 Cr | ₹13 Cr |
| ₹248 Cr | ₹238 Cr | ₹253 Cr | ₹366 Cr | ₹270 Cr | ₹208 Cr | ₹162 Cr | ₹128 Cr | ₹127 Cr | ₹128 Cr | ₹130 Cr | ₹109 Cr | ₹56 Cr | ₹54 Cr | ₹46 Cr | ₹35 Cr | ₹31 Cr | ₹29 Cr |
| ₹8 Cr | ₹3 Cr | ₹5 Cr | ₹20 Cr | ₹52 Cr | ₹57 Cr | ₹5 Cr | ₹1 Cr | ₹2 Cr | ₹23 L | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹5 Cr | ₹13 Cr | ₹15 Cr | ₹7 Cr | ₹2 Cr |
| ₹33,000 | ₹33,000 | ₹33,000 | ₹33,000 | ₹31,000 | ₹31,000 | ₹5 Cr | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹25,625 |
| ₹33,000 | ₹33,000 | ₹33,000 | ₹33,000 | ₹31,000 | ₹31,000 | ₹5 Cr | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹30,625 | ₹25,625 |
| ₹4 Cr | ₹6 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹14 Cr | ₹3 Cr | ₹3 Cr | ₹10 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹274 Cr | ₹250 Cr | ₹263 Cr | ₹397 Cr | ₹323 Cr | ₹267 Cr | ₹175 Cr | ₹130 Cr | ₹129 Cr | ₹128 Cr | ₹131 Cr | ₹110 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹50 Cr | ₹38 Cr | ₹32 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹216 Cr | ₹162 Cr | ₹144 Cr | ₹209 Cr | ₹159 Cr | ₹97 Cr | ₹39 Cr | ₹30 Cr | ₹34 Cr | ₹17 Cr | ₹20 Cr | ₹18 Cr | ₹23 Cr | ₹16 Cr | ₹18 Cr | ₹20 Cr | ₹13 Cr | ₹17 Cr |
| ₹234 Cr | ₹252 Cr | ₹180 Cr | ₹194 Cr | ₹185 Cr | ₹99 Cr | ₹98 Cr | ₹78 Cr | ₹80 Cr | ₹53 Cr | ₹43 Cr | ₹52 Cr | ₹55 Cr | ₹45 Cr | ₹35 Cr | ₹26 Cr | ₹23 Cr | ₹16 Cr |
| ₹38 Cr | ₹7 Cr | ₹3 Cr | ₹19 Cr | ₹2 Cr | ₹14 Cr | ₹4 Cr | ₹8 Cr | ₹8 Cr | ₹84 L | ₹36 L | ₹87 L | ₹99 L | ₹13 L | ₹55 L | ₹12 L | ₹1 Cr | ₹1 Cr |
| ₹12 Cr | ₹35 Cr | ₹37 Cr | ₹36 Cr | ₹38 Cr | ₹32 Cr | ₹13 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹69 Cr | ₹33 Cr | ₹40 Cr | ₹44 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹19 Cr | ₹15 Cr | ₹18 Cr | ₹13 Cr | ₹7 Cr | ₹5 Cr | ₹8 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr |
| ₹569 Cr | ₹488 Cr | ₹405 Cr | ₹502 Cr | ₹398 Cr | ₹258 Cr | ₹168 Cr | ₹137 Cr | ₹140 Cr | ₹91 Cr | ₹78 Cr | ₹79 Cr | ₹86 Cr | ₹71 Cr | ₹62 Cr | ₹57 Cr | ₹47 Cr | ₹42 Cr |
| ₹259 Cr | ₹216 Cr | ₹2 Cr | ₹67 Cr | ₹76 Cr | ₹76 Cr | ₹31 Cr | ₹20 Cr | ₹8 Cr | -₹1 Cr | -₹10 Cr | -₹6 Cr | -₹13 Cr | -₹13 Cr | -₹11 Cr | -₹8 Cr | ₹19 Cr | ₹21 Cr |
| ₹913 Cr | ₹814 Cr | ₹743 Cr | ₹899 Cr | ₹721 Cr | ₹526 Cr | ₹343 Cr | ₹267 Cr | ₹268 Cr | ₹219 Cr | ₹209 Cr | ₹189 Cr | ₹145 Cr | ₹130 Cr | ₹121 Cr | ₹107 Cr | ₹85 Cr | ₹74 Cr |
| ₹158 | ₹142 | ₹101 | ₹133 | ₹119 | ₹187 | ₹129 | ₹129 | ₹105 | ₹143 | ₹69 | ₹166 | ₹132 | ₹123 | ₹128 | ₹127 | ₹110 | ₹57 |
| ₹158 | ₹142 | ₹101 | ₹133 | ₹119 | ₹94 | ₹64 | ₹32 | ₹26 | ₹36 | ₹17 | ₹14 | ₹11 | ₹10 | ₹11 | ₹11 | ₹9 | ₹5 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹24 Cr | ₹42 Cr | -₹104 Cr | ₹58 Cr | ₹90 Cr | ₹119 Cr | ₹36 Cr | ₹24 Cr | ₹23 Cr | ₹14 Cr | ₹13 Cr | ₹12 Cr | ₹3 Cr | -₹2 Cr | ₹1 Cr | ₹6 Cr | ₹0 | ₹0 |
| ₹80 Cr | ₹46 Cr | ₹170 Cr | ₹56 Cr | ₹31 Cr | ₹24 Cr | ₹16 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹14 Cr | ₹10 Cr | ₹9 Cr | ₹0 | ₹0 |
| -₹48 Cr | -₹62 Cr | ₹39 Cr | -₹125 Cr | -₹111 Cr | -₹64 Cr | -₹22 Cr | -₹6 Cr | -₹19 Cr | -₹6 Cr | -₹31 L | -₹8 L | -₹2 Cr | ₹2 Cr | -₹2 Cr | -₹8 Cr | ₹0 | ₹0 |
| ₹56 Cr | ₹26 Cr | ₹105 Cr | -₹11 Cr | ₹10 Cr | ₹79 Cr | ₹30 Cr | ₹38 Cr | ₹23 Cr | ₹27 Cr | ₹30 Cr | ₹29 Cr | ₹18 Cr | ₹15 Cr | ₹10 Cr | ₹6 Cr | ₹0 | ₹0 |
| ₹58 Cr | ₹22 Cr | ₹92 Cr | -₹22 Cr | ₹69 L | ₹44 Cr | ₹21 Cr | ₹25 Cr | ₹17 Cr | ₹22 Cr | ₹25 Cr | ₹28 Cr | ₹17 Cr | ₹15 Cr | ₹9 Cr | ₹4 Cr | ₹0 | ₹0 |
| -₹48 Cr | -₹15 Cr | -₹11 Cr | -₹93 Cr | -₹75 Cr | -₹109 Cr | -₹28 Cr | -₹13 Cr | -₹12 Cr | -₹8 Cr | -₹31 Cr | -₹17 Cr | -₹9 Cr | -₹8 Cr | -₹15 Cr | -₹17 Cr | ₹0 | ₹0 |
| ₹24 Cr | -₹6 Cr | -₹97 Cr | ₹131 Cr | ₹62 Cr | ₹75 Cr | ₹3 Cr | -₹13 Cr | ₹2 Cr | -₹13 Cr | ₹5 Cr | -₹11 Cr | -₹8 Cr | -₹7 Cr | ₹6 Cr | ₹11 Cr | ₹0 | ₹0 |
| ₹35 Cr | ₹43 L | -₹16 Cr | ₹16 Cr | -₹12 Cr | ₹10 Cr | -₹4 Cr | -₹42 L | ₹7 Cr | ₹47 L | -₹44 L | -₹18 L | ₹86 L | -₹36 L | ₹43 L | -₹1 Cr | ₹0 | ₹0 |
| ₹3 Cr | ₹2 Cr | ₹18 Cr | ₹2 Cr | ₹14 Cr | ₹4 Cr | ₹8 Cr | ₹8 Cr | ₹84 L | ₹36 L | ₹87 L | ₹99 L | ₹13 L | ₹55 L | ₹12 L | ₹1 Cr | ₹0 | ₹0 |
| ₹37 Cr | ₹3 Cr | ₹2 Cr | ₹18 Cr | ₹2 Cr | ₹14 Cr | ₹4 Cr | ₹8 Cr | ₹8 Cr | ₹84 L | ₹42 L | ₹81 L | ₹99 L | ₹19 L | ₹55 L | ₹12 L | ₹0 | ₹0 |
Fundamental Ratios
Consolidated
Standalone
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 4 out of 9 oscillators
RSI
63.88Buy
STOCH %K
72.25Neutral
MACD Level(12,26)
3.81Buy
Ultimate Oscillator
48.94Sell
Aroon Oscillator
-82.00Sell
BOP
-0.24Sell
CCI
242.23Sell
Williams %R
-27.75Neutral
Momentum
24.95Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
338.25Buy
SMA 9
334.39Buy
EMA 21
333.24Buy
SMA 21
330.94Buy
EMA 50
330.55Buy
SMA 50
332.34Buy
EMA 200
357.36Sell
SMA 200
340.17Buy
WMA 20
334.01Buy
Pivot
Pivot
Classic
Resistance 5
428.90
Resistance 4
408.90
Resistance 3
388.90
Resistance 2
368.90
Resistance 1
360.80
Pivot
348.90
Support 1
340.80
Support 2
328.90
Support 3
308.90
Support 4
288.90
Support 5
268.90
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 58.59% | 58.29% | 59.19% | 59.19% | 59.19% | 59.19% |
| 2.19% | 1.98% | 1.18% | 1.12% | 1.09% | 1.05% |
| 0.23% | 1.22% | 1.30% | 1.33% | 1.50% | 0.88% |
| 1.69% | 1.69% | 1.66% | 1.66% | 1.66% | 1.64% |
| 37.30% | 36.82% | 36.67% | 36.70% | 36.56% | 37.24% |
Bulk & block deals
Name
Weststone Management Consultancy Private Limited
Nk Securities Research Private Limited
Qe Securities Llp
Junomoneta Finsol Private Limited
Microcurves Trading Private Limited
Blitzquant Research Llp
Grt Strategic Ventures Llp
Irage Broking Services Llp
Jump Trading Financial India Private Limited
Vinsul Makardi Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 22 Jul 2026 | Sell | 6.66 Cr | ₹332.91 | 2 L | Bulk | 0.594085 | NSE |
| 29 Jun 2026 | Purchase | 25.12 Cr | ₹346.96 | 7.24 L | Bulk | 2.150235 | NSE |
| 29 Jun 2026 | Purchase | 18.37 Cr | ₹347.89 | 5.28 L | Bulk | 1.568118 | NSE |
| 29 Jun 2026 | Purchase | 16.72 Cr | ₹347.67 | 4.81 L | Bulk | 1.428359 | NSE |
| 29 Jun 2026 | Purchase | 15.73 Cr | ₹347.27 | 4.53 L | Bulk | 1.345888 | NSE |
| 29 Jun 2026 | Purchase | 10.34 Cr | ₹346.86 | 2.98 L | Bulk | 0.885784 | NSE |
| 29 Jun 2026 | Purchase | 7.45 Cr | ₹347.06 | 2.15 L | Bulk | 0.637982 | NSE |
| 29 Jun 2026 | Purchase | 6.66 Cr | ₹347.84 | 1.92 L | Bulk | 0.568938 | NSE |
| 29 Jun 2026 | Purchase | 6.31 Cr | ₹348.05 | 1.81 L | Bulk | 0.538482 | NSE |
| 29 Jun 2026 | Purchase | 5.90 Cr | ₹347.43 | 1.70 L | Bulk | 0.504046 | NSE |
Insider trading & SAST
Client name
Anil Jain
Anil Champalal Jain
Anil Jain
Anil Champalal Jain
Sajankumar Bajaj
Anil Jain
Anil Champalal Jain
Anil Champalal Jain
Sajankumar Rameshwarlal Bajaj
Anil Champalal Jain
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 Jun 2026 | Promoter | Acquisition | 0.29 | 6.05 | 0 | — | 1 L | 12 Jun 2026 | Market | 20,36,544 | SAST | 29(1) | — |
| 15 Jun 2026 | Promoter Group | Acquisition | 0.297065 | 6.05 | 2.97 Cr | ₹297.30 | 1 L | 12 Jun 2026 | Market Purchase | 20,36,544 | Insider Trading | — | Equity Shares |
| 09 Apr 2026 | Promoter | Acquisition | 1.35 | 5.75 | 0 | — | 4.55 L | 18 Mar 2026 | Allotment | 19,36,544 | SAST | 29(1) | — |
| 09 Apr 2026 | Promoter | Acquisition | 0.02 | 4.67 | 0 | — | 7.60 K | 16 Mar 2026 | Market | 14,74,375 | SAST | 29(1) | — |
| 09 Apr 2026 | Other | Acquisition | 1.35 | 36.62 | 0 | — | 4.55 L | 18 Mar 2026 | Conv. of Warrants | 1,23,25,774 | SAST | 29(1) | — |
| 09 Apr 2026 | Other | Acquisition | — | 4.64 | 0 | — | 3 K | 13 Mar 2026 | Market | 14,66,775 | SAST | 29(1) | — |
| 09 Apr 2026 | Promoter | Acquisition | 0.02 | 4.69 | 0 | — | 7.09 K | 17 Mar 2026 | Market | 14,81,470 | SAST | 29(1) | — |
| 21 Mar 2026 | Promoter Group | Acquisition | 1.351864 | 5.75 | 0 | ₹0 | 4.55 L | 18 Mar 2026 | Conversion of security | 19,36,544 | Insider Trading | — | Equity Shares |
| 21 Mar 2026 | Promoter | Acquisition | 1.351864 | 36.62 | 0 | ₹0 | 4.55 L | 18 Mar 2026 | Conversion of security | 1,23,25,774 | Insider Trading | — | Equity Shares |
| 20 Mar 2026 | Promoter Group | Acquisition | 0.021077 | 4.69 | 0 | — | 7.09 K | 17 Mar 2026 | Market Purchase | 14,81,470 | Insider Trading | — | Equity Shares |
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Bajaj Healthcare Ltd mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. The various product categories
Corporate Actions
Date
Type
Details
Company details
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Bajaj Healthcare Share Price
350.15-2.55 (-0.72%)
-24.45% past 1 Year
News
Bajaj Healthcare Q1 EBITDA rises year-on-year with improved margin profile
Equity
BAJAJHCARE
Bajaj Healthcare Q1 FY earnings show healthy year-on-year revenue growth trend
Equity
BAJAJHCARE
Bajaj Healthcare Q1 standalone net profit rises 16 percent year-on-year
Equity
BAJAJHCARE
Bajaj Healthcare schedules Q1 FY2026 earnings conference call on July 21
Equity
BAJAJHCARE
Bajaj Healthcare co-promoter increases stake via open market share purchase
Equity
BAJAJHCARE
Bajaj Healthcare Q4 FY Net Loss Widens to Rs 19.40 Crores vs Profit of Rs 11.20 Crores YoY
Equity
BAJAJHCARE
Bajaj Healthcare reports Profit after tax of Rs -19.41 Crores, in the March 2026 quarter
Equity
BAJAJHCARE
Bajaj Healthcare submits board meeting intimation
Equity
BAJAJHCARE
Bajaj Healthcare informs about disclosure
Equity
BAJAJHCARE
Bajaj Healthcare informs about disclosure
Equity
BAJAJHCARE
Bajaj Healthcare informs about disclosure
Equity
BAJAJHCARE
Bajaj Healthcare informs about board meeting
Equity
BAJAJHCARE
Bajaj Healthcare informs about scrutinizer’s report
Equity
BAJAJHCARE
Bajaj Healthcare - Quaterly Results
Equity
BAJAJHCARE
Bajaj Healthcare Reappoints Sajankumar Bajaj as Chairman and Managing Director.
Equity
BAJAJHCARE
Bajaj Healthcare Q3 FY26 EBITDA Rises 42% YoY to Rs 30.70 Crores with Margin Expansion.
Equity
BAJAJHCARE
Bajaj Healthcare Q3 FY26 Results: Revenue Growth 31% YoY, PAT Surges 7% YoY
Equity
BAJAJHCARE
Bajaj Healthcare reports Profit after tax of 16.10 Crores, in the December 2025 quarter
Equity
BAJAJHCARE
Bajaj Healthcare rises on getting nod to conduct Clinical Trial, Bioequivalence Study of Suvorexant Tablets
Equity
BAJAJHCARE
Bajaj Healthcare Receives CDSCO SEC Recommendation for Phase III Trials of Suvorexant Tablets.
Equity
BAJAJHCARE

